Arsenic trioxide (oral)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Arsenic trioxide (oral), covering 2025-05-30 to 2025-05-30. Get the full timeline:
Most recent: Clinical Trial Update: Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia [Phase 2]